BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 12673952)

  • 1. [Biomedical imaging in pharmacology with nuclear medical imaging methodologies: positron emission tomography (PET) and single photon emission computed tomography (SPECT)].
    Saji H; Iida Y
    Nihon Yakurigaku Zasshi; 2003 Mar; 121(3):181-91. PubMed ID: 12673952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single photon emission computed tomography and positron emission tomography in cancer imaging.
    Coleman RE
    Cancer; 1991 Feb; 67(4 Suppl):1261-70. PubMed ID: 1991287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomography and single-photon emission computed tomography in substance abuse research.
    Volkow ND; Fowler JS; Wang GJ
    Semin Nucl Med; 2003 Apr; 33(2):114-28. PubMed ID: 12756644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPECT and PET imaging of brain tumors.
    Hustinx R; Alavi A
    Neuroimaging Clin N Am; 1999 Nov; 9(4):751-66. PubMed ID: 10517943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in imaging endogenous or transferred gene expression utilizing radionuclide technologies in living subjects: applications to breast cancer.
    Berger F; Gambhir SS
    Breast Cancer Res; 2001; 3(1):28-35. PubMed ID: 11250742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPECT and PET imaging in Alzheimer's disease.
    Valotassiou V; Malamitsi J; Papatriantafyllou J; Dardiotis E; Tsougos I; Psimadas D; Alexiou S; Hadjigeorgiou G; Georgoulias P
    Ann Nucl Med; 2018 Nov; 32(9):583-593. PubMed ID: 30128693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is altropane SPECT more sensitive to fluoroDOPA PET for detecting early Parkinson's disease?
    Fernandez HH; Friedman JH; Fischman AJ; Noto RB; Lannon MC
    Med Sci Monit; 2001; 7(6):1339-43. PubMed ID: 11687754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High resolution PET, SPECT and projection imaging in small animals.
    Green MV; Seidel J; Vaquero JJ; Jagoda E; Lee I; Eckelman WC
    Comput Med Imaging Graph; 2001; 25(2):79-86. PubMed ID: 11137783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography and single-photon emission computed tomography brain imaging in the evaluation of dementia.
    Van Heertum RL; Tikofsky RS
    Semin Nucl Med; 2003 Jan; 33(1):77-85. PubMed ID: 12605358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a PET/SPECT agent for amyloid imaging in Alzheimer's disease.
    Wang Y; Klunk WE; Debnath ML; Huang GF; Holt DP; Shao L; Mathis CA
    J Mol Neurosci; 2004; 24(1):55-62. PubMed ID: 15314250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nuclear medicine imaging in neurodegenerative dementias].
    Gratz S; Hahn U; Kaiser JW; Jarnig M; Schwarz J; Förstl H
    Dtsch Med Wochenschr; 2008 May; 133 Suppl 1():S5-7. PubMed ID: 18437639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular imaging in evaluation of in vivo behavior of drugs].
    Saji H
    Nihon Rinsho; 2007 Feb; 65(2):363-9. PubMed ID: 17302285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of single-photon emission computed tomography/computed tomography in benign and malignant bone disease.
    Horger M; Bares R
    Semin Nucl Med; 2006 Oct; 36(4):286-94. PubMed ID: 16950146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional peak dose dyskinesia in patients with Parkinson's disease.
    Baik JS; Lyoo CH; Lee JH; Chung SJ; Lee MS
    Parkinsonism Relat Disord; 2009 Jul; 15(6):475-6. PubMed ID: 19084463
    [No Abstract]   [Full Text] [Related]  

  • 15. Radiotracers and analytical approaches in positron and single-photon emission tomography.
    Frey KA
    Adv Neurol; 2000; 83():61-7. PubMed ID: 10999189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of positron-emission tomography/single-photon emission computed tomography imaging probes for in vivo detection of beta-amyloid plaques in Alzheimer's brains.
    Ono M
    Chem Pharm Bull (Tokyo); 2009 Oct; 57(10):1029-39. PubMed ID: 19801854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Imaging of the Dopaminergic System in Idiopathic Parkinson's Disease.
    de Natale ER; Niccolini F; Wilson H; Politis M
    Int Rev Neurobiol; 2018; 141():131-172. PubMed ID: 30314595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling of receptor ligand data in PET and SPECT imaging: a review of major approaches.
    Meyer JH; Ichise M
    J Neuroimaging; 2001 Jan; 11(1):30-9. PubMed ID: 11198524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A non-parametric bootstrap approach for analysing the statistical properties of SPECT and PET images.
    Buvat I
    Phys Med Biol; 2002 May; 47(10):1761-75. PubMed ID: 12069092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of functional genomics and proteomics on radionuclide imaging.
    Haberkorn U; Altmann A; Mier W; Eisenhut M
    Semin Nucl Med; 2004 Jan; 34(1):4-22. PubMed ID: 14735455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.